Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial

Alice C. Wei, Fang Shu Ou, Qian Shi, Xiomara Carrero, Eileen M. O’Reilly, Jeffrey Meyerhardt, Robert A. Wolff, Hedy L. Kindler, Douglas B. Evans, Vikram Deshpande, Joseph Misdraji, Eric Tamm, Dushyant Sahani, Malcolm Moore, Elliot Newman, Nipun Merchant, Jordan Berlin, Laura W. Goff, Peter Pisters, Mitchell C. Posner

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences